For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...
More than a decade after the Drug Quality and Security Act (DQSA) of 2013 created the 503B category, the central question ...
Lastly, Insilico Medicine has inked a $120 million deal with Qilu Pharmaceuticals. The company will be using Insilico’s ...
Discover how access barriers evolve across the biopharma brand lifecycle, from launch to loss of exclusivity, and how to ...
In the final part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, explains how federated ...
Morris & Dickson's acquisition of Prodigy Health strengthens its specialty pharmaceutical distribution and expands access to ...
In today’s Pharma Pulse, extreme weather tests the resilience of community pharmacies, while CMS proposes a near-flat 0.09% update for Medicare Advantage and Part D payments in 2027.
In today’s Pharma Pulse, global pharmaceutical production hits a surge as manufacturers brace for US tariff shifts, while a new study reveals how smart speakers are slashing A1C levels for older ...
In the second part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, describes how AI-driven ...
How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike. The status quo ...
The new Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.
The FDA ImportShield Program centralizes import review, increasing processing speed by 66% and volume capacity by 33%, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results